Global Urology Devices Market 2018-2022 - Increasing Prevalence of Urological Diseases

Global Urology Devices Market 2018-2022 - Increasing Prevalence of Urological Diseases

PR Newswire

DUBLIN, Feb. 9, 2018

DUBLIN, Feb. 9, 2018 /PRNewswire/ --

The "Global Urology Devices Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Global urology devices market to grow at a CAGR of 5.08 % during the period 2018-2022.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the major drivers for this market is the increasing prevalence of urological diseases. As of 2015, 100 in every 1,000 individuals worldwide were affected by CKD. The CKD may get worse over time and lead to kidney failure or ESRD. Globally, it is estimated that more than two million ESRD patients receive renal replacement therapy (RRT) regularly in the form of dialysis. According to the Centers for Disease Control and Prevention (CDC) report in 2017, approximately 30 million individuals, which accounted for 15% of the US adults, were affected by CKD. In 2014, around 118,000 individuals in the US started taking treatment for ESRD and 662,000 were living with a kidney transplant. Men are 64% more likely to develop ESRD when compared with women.

The latest trend gaining momentum in the market is emergence of innovative technologies. Continuous improvement in technology led to the development of urology devices with superior quality and safety. For instance, in October 2015, Boston Scientific launched LithoVue, first single-use digital flexible ureteroscope developed to access the upper urinary tract for diagnosing and treating kidney stones, and other kidney, ureter, and bladder conditions. NeoTract (acquired by Teleflex) introduced UroLift system, a novel minimally invasive treatment for BPH.

Key Vendors

Key Topics Covered

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation by Application

Part 09: Customer Landscape

Part 10: Market Segmentation by End-Users

Part 11: Regional Landscape

Part 12: Decision Framework

Part 13: Drivers and Challenges

Part 14: Market Trends

Part 15: Vendor Landscape

Part 16: Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/j5tchv/global_urology?w=5

Media Contact:


Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Voltar noticias em Inglês